Sorin S.p.A. (SRN) - Financial and Strategic SWOT Analysis Review
Reference Code: GDME817FSA Publication Date: MAR 2012
Via Benigno Crespi, 17 Phone +39 2 69969711 Revenue 743.40 (million EUR)
Milano, Lombardia Fax Net Profit 58 (million EUR)
20159 Website www.sorin.com Employees 3,750
SRN [Italian SE
Italy Exchange (Mercato Continuo Industry Medical Equipment
Italia)]
Company Overview
Sorin S.p.A. (Sorin) carries out the development of medical technologies for cardiac surgery. It also offers innovative therapies for
cardiac rhythm dysfunctions, and interventional cardiology. Sorin focuses on three main therapeutic areas, namely,
cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve
repair and replacement. The company's research and development (R&D) activities focus on the development of various product
innovations in Cardiopulmonary business unit. Annually, more than one million patients are treated with its devices in more than
80 countries worldwide.
Key Executives SWOT Analysis
Name Title Sorin S.p.A., SWOT Analysis
Andre Michel Ballester Chief Executive Officer Strengths Weaknesses
Rosario Bifulco Director
Broad Product Portfolio Fluctuating Revenues
Paolo Braghieri Director, Independent
Focused Research and Product Recalls
Andrea Bovone Director
Development Activities
Paolo Baessato Director
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData Opportunities Threats
Share Data Global Cardiovascular Devices Rapid Technological Changes
Sorin S.p.A. Market
Regulatory Environment
Share Price (EUR) as on 21-Mar- 1.43 Regulatory Approvals and New
2012 Product Launches
EPS (EUR) 0.12
Market Cap (million EUR) 683 Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
Enterprise Value (million EUR) 786
Shares Outstanding (million) 478
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Financial Performance Recent Developments
Jul 29, 2011 Sorin Reports Total Revenues Of €191.9m For
Q2 2011
May 05, 2011 Sorin Group Receives CE Mark Approval For
PARADYM RF ICDs And CRT-D
Apr 29, 2011 Sorin Reports Net Revenues Of €182.3m In
Q1 2011
Mar 17, 2011 Sorin Reports Net Profit of €39.1m In 2010
Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Sorin S.p.A. (SRN) - Financial and Strategic SWOT Analysis Reference Code: GDME817FSA
Review
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 4
Section 1 - About the Company.......................................................................................................................................................... 5
Sorin S.p.A. - Key Facts ..................................................................................................................................................................... 5
Sorin S.p.A. - Key Employees ............................................................................................................................................................ 6
Sorin S.p.A. - Key Employee Biographies .......................................................................................................................................... 7
Sorin S.p.A. - Major Products and Services ....................................................................................................................................... 8
Sorin S.p.A. - Medical Equipment Pipeline Products Data ............................................................................................................... 10
Sorin S.p.A. Pipeline Products by Equipment Type ...................................................................................................................... 10
Sorin S.p.A. Pipeline Products by Development Stage................................................................................................................. 13
Sorin S.p.A. - History ........................................................................................................................................................................ 16
Sorin S.p.A. - Company Statement .................................................................................................................................................. 20
Sorin S.p.A. - Locations And Subsidiaries ........................................................................................................................................ 22
Head Office ................................................................................................................................................................................... 22
Sorin S.p.A. - Key Manufacturing Facilities ...................................................................................................................................... 23
Section 2 – Company Analysis ......................................................................................................................................................... 24
Sorin S.p.A. - Business Description.................................................................................................................................................. 24
Business Description - Cardiovascular ......................................................................................................................................... 24
Cardiovascular - Overview ........................................................................................................................................................ 24
Cardiovascular - Financials ....................................................................................................................................................... 25
Cardiovascular - Market View ................................................................................................................................................... 25
Cardiovascular - Technology..................................................................................................................................................... 25
Sorin S.p.A. - Corporate Strategy ..................................................................................................................................................... 26
Sorin S.p.A. - SWOT Analysis .......................................................................................................................................................... 27
SWOT Analysis - Overview........................................................................................................................................................... 27
Sorin S.p.A. - Strengths ................................................................................................................................................................ 27
Strength - Broad Product Portfolio ............................................................................................................................................ 27
Strength - Focused Research and Development Activities ....................................................................................................... 27
Strength - Geographical Diversity ............................................................................................................................................. 27
Sorin S.p.A. - Weaknesses ........................................................................................................................................................... 27
Weakness - Fluctuating Revenues ............................................................................................................................................ 27
Weakness - Product Recalls ..................................................................................................................................................... 28
Sorin S.p.A. - Opportunities .......................................................................................................................................................... 28
Opportunity - Global Cardiovascular Devices Market ................................................................................................................ 28
Opportunity - Regulatory Approvals and New Product Launches ............................................................................................. 28
Opportunity - Market Growth in Emerging Markets ................................................................................................................... 29
Sorin S.p.A. - Threats ................................................................................................................................................................... 29
Threat - Rapid Technological Changes ..................................................................................................................................... 29
Threat - Regulatory Environment .............................................................................................................................................. 29
Threat - Competitive Landscape ............................................................................................................................................... 29
Sorin S.p.A. - Key Competitors......................................................................................................................................................... 30
Section 3 – Company Financial Ratios ............................................................................................................................................. 31
Financial Ratios - Capital Market Ratios........................................................................................................................................... 31
Financial Ratios - Annual Ratios ...................................................................................................................................................... 31
Sorin S.p.A. (SRN) - Financial and Strategic SWOT Analysis Reference Code: GDME817FSA
Review
Source : www.globalcompanyintelligence.com Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Performance Chart ........................................................................................................................................................................... 33
Financial Performance...................................................................................................................................................................... 33
Financial Ratios - Interim Ratios....................................................................................................................................................... 34
Financial Ratios - Ratio Charts ......................................................................................................................................................... 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 36
Sorin S.p.A., Medical Equipment, Deals By Year,